HIV-related lipodystrophy and related factors

This publication has 72 references indexed in Scilit:

• Risk factors for the HIV‐associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment
  HIV Medicine, 2002
• HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the Nucleus
  Journal of Biological Chemistry, 2001
• Apoprotein C-III and E-Containing Lipoparticles Are Markedly Increased in HIV-Infected Patients Treated with Protease Inhibitors: Association with the Development of Lipodystrophy
  Journal of Clinical Endocrinology & Metabolism, 2001
• Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
  Clinical Infectious Diseases, 2001
• Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group
  Clinical Infectious Diseases, 2000
• Effect of short-course of antiretroviral agents on serum triglycerides of healthy individuals
  AIDS, 2000
• Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy
  The Lancet, 1999
• Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
  The Lancet, 1998
• Normal triglyceride levels in early HIV-1 infection
  AIDS, 1994
• High triglyceride levels as a predictor of mortality in AIDS patients
  AIDS, 1993